Being in constant communication with our customers, we try to discover and solve today and future needs. This enables timely decisions, believing that we apply...

30MARCH
TRPharm and Sigma Tau Rare Disease Announce Agreement for Turkey
TRPharm and Sigma Tau Rare Disease Announce Agreement for Turkey

TRPharm and Sigma Tau Rare Disease Announce Agreement for Turkey March 1st, 2016 TRPharm and Sigma Tau Rare Disease Ltd enter into a distribution agreement for priority orphan product in Turkey TRPharm and Sigma Tau announced today a Distribution Agreement for an orphan product of Sigma Tau. As part of the agreement TRPharm will seek […]

11MARCH
Dr. Reddy’s and TRPharm Announce Strategic Collaboration in Turkey
Dr. Reddy’s and TRPharm Announce Strategic Collaboration in Turkey

Dr. Reddy’s and TRPharm Announce Strategic Collaboration in Turkey Dr Reddy’s and TRPharm entered into a strategic collaboration agreement for manufacture and commercialization of a portfolio of biosimilar drugs in Turkey Istanbul, Turkey, March 10, 2016 Dr. Reddy’s and TRPharm announced today a strategic collaboration agreement involving 3 biosimilar products. A total of three products […]

13JANUARY
TR-Pharm and CrystalGenomics Announce Licensing Agreement for Turkey and MENA
TR-Pharm and CrystalGenomics Announce Licensing Agreement for Turkey and MENA

TR-Pharm and CrystalGenomics Announce Licensing Agreement for Turkey and MENA January 13th, 2015 TR-Pharm and CrystalGenomics entered into a licensing agreement for commercialization of CrystalGenomics’ Acelex  in Turkey and Middle East & North Africa region TR-Pharm and CrystalGenomics announced today a Licensing and Supply Agreement for CrystalGenomics’ Acelex® (polmacoxib). The product, developed by CrystalGenomics, is a […]